Bayramoglu Tepe Neslihan, Bozgeyik Esra, Bozdag Zehra, Balat Ozcan, Ozcan Huseyin Caglayan, Ugur Mete Gurol
Department of Obstetrics and Gynecology, University of Gaziantep, Gaziantep, Turkey.
Department of Medical Services and Techniques, Vocational School of Health Services, Adiyaman University, Adiyaman, Turkey.
Reprod Biol. 2021 Sep;21(3):100536. doi: 10.1016/j.repbio.2021.100536. Epub 2021 Jul 20.
Cervical cancer markedly threatens women's health worldwide and currently ranks fourth leading cause of cancer mortality in women according to recent global cancer statistics. Recent advances have proven that not only tumor suppressor and oncogenes but also non-coding RNAs including micro RNAs (miRNAs) have significant impact in the development and progression of cervical cancers. Previous studies have identified many cancer-specific miRNAs for the early detection of cervical cancers. However, the diagnostic and prognostic use of autophagy-associated miRNAs for the cervical squamous cell cancer (SCC) cases and high-grade squamous intraepithelial lesion (HSIL) have not been uncovered. In the present study, we revealed that miRNAs are differentially expressed in both cervical SCC and HSIL. A total of 35 HSIL, 35 cervical SCC and 30 healthy controls were enrolled for the present study. Total RNA including miRNAs were isolated from the FFPE tissue samples and miRNA expression levels were quantified by quantitative PCR. Predicted miRNA targets of autophagy related genes were determined using miRNA-target prediction algorithms. MiR-143, miR-372, miR-375 and miR-30c were markedly downregulated in HSIL and cervical SCC. MiR-130a was significantly upregulated in the cervical SCC group compared to HSIL and control groups. MiR-30a, miR-520e, miR-548c and miR-372 were significantly associated with the overall survival of cervical SCC patients and these miRNAs were determined to be significant diagnostic markers as revealed by ROC analysis. Together, these results indicate that autophagy-associated miRNAs are potentially valuable for the differential diagnosis and targeted therapy to cervical cancer.
宫颈癌在全球范围内严重威胁着女性健康,根据最近的全球癌症统计数据,它目前是女性癌症死亡的第四大主要原因。最近的研究进展证明,不仅肿瘤抑制基因和癌基因,而且包括微小RNA(miRNA)在内的非编码RNA在宫颈癌的发生和发展中都具有重要影响。先前的研究已经鉴定出许多用于宫颈癌早期检测的癌症特异性miRNA。然而,自噬相关miRNA在宫颈鳞状细胞癌(SCC)病例和高级别鳞状上皮内病变(HSIL)中的诊断和预后用途尚未被发现。在本研究中,我们发现miRNA在宫颈SCC和HSIL中均有差异表达。本研究共纳入了35例HSIL、35例宫颈SCC和30例健康对照。从福尔马林固定石蜡包埋(FFPE)组织样本中分离出包括miRNA在内的总RNA,并通过定量PCR对miRNA表达水平进行定量。使用miRNA靶标预测算法确定自噬相关基因的预测miRNA靶标。miR-143、miR-372、miR-375和miR-30c在HSIL和宫颈SCC中显著下调。与HSIL和对照组相比,miR-130a在宫颈SCC组中显著上调。miR-30a、miR-520e、miR-548c和miR-372与宫颈SCC患者的总生存期显著相关,并且如ROC分析所示,这些miRNA被确定为重要的诊断标志物。总之,这些结果表明自噬相关miRNA对宫颈癌的鉴别诊断和靶向治疗具有潜在价值。